Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

Figure 2

Receiver operating characteristic (ROC) curve analysis in the diagnosis of esophageal squamous cell carcinoma (ESCC). (a) ROC curve for serum autoantibodies against STIP1 for patients with ESCC versus normal controls in the training cohort. (b) ROC curve for serum autoantibodies against STIP1 for patients with early-stage ESCC versus normal controls in the training cohort. (c) ROC curve for serum autoantibodies against STIP1 for patients with ESCC versus normal controls in the validation cohort. (d) ROC curve for serum autoantibodies against STIP1 for patients with early-stage ESCC versus normal controls in the validation cohort.

(a)

(b)

(c)

(d)